ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,23%
Euro vs US Dollar
1,0715
-0,02%
Bitcoin
57.369,25
-1,49%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Pulmonx Corporation (LUNG)

  7. Pulmonx Corporation (LUNG) News

LUNG Pulmonx Corporation

9,67
2,06 (27,07%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Pulmonx Corporation LUNG NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
2,06 27,07% 9,67 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
7,70 7,64 8,15 7,72 7,61
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202422:05GLOBEPulmonx Reports First Quarter 2024 Financial Results
10.4.202422:05GLOBEPulmonx to Report First Quarter 2024 Financial Results on..
02.4.202422:05GLOBEPulmonx Announces Appointment of Mehul Joshi as Chief..
15.3.202422:00GLOBEPulmonx Announces Inducement Grants under Nasdaq Listing..
08.3.202402:02EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06.3.202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27.2.202422:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27.2.202402:48BWPulmonx meldet Behandlung des ersten Patienten mit dem..
27.2.202402:40BWPulmonx annonce le traitement du premier patient par système..
27.2.202402:39BWPulmonx annuncia il trattamento del primo paziente con il..
27.2.202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202414:00BWPulmonx Announces Treatment of the First Patient with the..
22.2.202422:31EDGAR2Form 144 - Report of proposed sale of securities
21.2.202422:08EDGAR2Form 8-K - Current report
21.2.202422:06GLOBEPulmonx Reports Fourth Quarter and Full Year 2023 Financial..
21.2.202422:05EDGAR2Form 8-K - Current report
21.2.202422:05GLOBEPulmonx Announces Retirement of CEO Glen French and..
17.2.202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:14EDGAR2Form 144 - Report of proposed sale of securities
14.2.202412:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202421:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202423:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202422:05GLOBEPulmonx to Report Fourth Quarter and Full Year 2023..
31.1.202422:34EDGAR2Form 144 - Report of proposed sale of securities
24.1.202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202422:28EDGAR2Form 144 - Report of proposed sale of securities
18.1.202423:06EDGAR2Form 144 - Report of proposed sale of securities
27.12.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.12.202300:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202322:25EDGAR2Form 144 - Report of proposed sale of securities
21.12.202322:43EDGAR2Form 144 - Report of proposed sale of securities
11.12.202315:00GLOBEThe Honest Company Announces Appointment of Michael Barkley,..
05.12.202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202323:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202323:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202300:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202322:24EDGAR2Form 144 - Report of proposed sale of securities
15.11.202322:05GLOBEPulmonx to Present at the Piper Sandler 35th Annual..
03.11.202321:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.10.202321:05GLOBEPulmonx to Participate at Upcoming Investor Conferences
30.10.202321:06EDGAR2Form 8-K - Current report
30.10.202321:05GLOBEPulmonx Reports Record Third Quarter 2023 Financial Results
26.10.202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.10.202323:10EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
LUNG
Pulmonx
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten